Corporate Overview

Corporate Overview

Why invest in Biolife Solutions?
  • Commitment to shareholders

    We are focused on building long-term value through disciplined growth, operational excellence, and transparent communication with investors.

  • Enabling the future of cell & gene therapy

    BioLife Solutions provides mission-critical tools that preserve the integrity of cells, the foundation of every cell and gene therapy. Demand for reliable biopreservation and processing solutions is rapidly accelerating.

  • Proven portfolio of essential tools

    Our products and automated cell processing systems are integrated across the CGT workflow. They reduce variability and enable scalable manufacturing.

  • Trusted by industry leaders

      BioLife’s solutions are used   by top cell and gene therapy developers, CDMOs, and academic centers around the globe. Our strong customer base and recurring consumables revenue model create stability and growth potential.

  • Commitment to shareholders

    We are focused on building long-term value through disciplined growth, operational excellence, and transparent communication with investors.

View our Financials

Our Mission

At BioLife Solutions, it is our mission to protect the integrity of cells and provide trusted tools, services, and expertise that can enable our customers to advance the development and delivery of cell and gene therapies.

Learn More

Our Market

With nearly 2,000 active clinical trials in the cell and gene therapy sector, demand for reliable biopreservation and cell processing tools has never been greater. BioLife is at the forefront of supporting this growth.

Learn More

Our Strategy

We deliver GMP-ready, scalable solutions that reduce risk, streamline operations, and accelerate therapy commercialization worldwide.

Learn More

Our solutions are embedded in CGT workflows
  • Collection

    Safely store and transport harvested cells from collection to processing





    BioT™ Intra-campus Transporters
     
    HypoThermosol® FRS Storage & Shipping Media

    Learn More

  • Formulation

    Stabilize starting materials through expansion and cryopreservation

    CryoStor® Freeze Media
     
    BloodStor® Media
     
    nLiven PR™ Human Platelet Lysate (hPL)
     
    Stemulate® hPL

    Learn More

  • Fill & Packaging

    Minimize variability between samples to ensure batch consistency and maximum recovery

    CellSeal® Connect Closed System Vials
     
    Signata CT-5™ Closed Fluid Management System
     
    CellSeal® AF-500 Automated Fill & Seal System

    Learn More

  • Intra-Campus Transport

    Ensure sample safety with insulated transporters





    BioT™ Intra-campus Transporters
     
    Ice Recrystallization Inhibitors

    Learn More

  • Thawing

    Safeguard consistent sample viability while minimizing contamination risk during thawing




    ThawSTAR®
     
    Water-free, automated thawing systems for various vial types

    Learn More

Global industry leader supporting CGT innovation
  • 17+ commercialized therapies
  • 700+ scientific citations
  • 700+ master file references
  • 70% share of US-based clinical trials

We believe the promise of cell and gene therapies starts with the integrity of a single cell

Advancing the future of cell and gene therapy

The human body can heal itself. Cell and gene therapies are designed to augment the patient’s ability to fight disease but only if the living cells behind those therapies remain viable and functional throughout the production processes. At BioLife Solutions, our mission is to protect the integrity of cells and provide trusted tools, services, and expertise that can enable our customers to advance the development and delivery of cell and gene therapies. We believe the future of cell and gene therapies hinges on the integrity of every single cell and we are here to protect that promise.

We understand the technical demands of bioprocessing in this field, and our advanced biopreservation expertise, cell culture optimization products, innovative storage systems, and closed-system manufacturing solutions are designed to enhance process efficiency, maintain cellular viability, and ensure reproducibility at every stage. Whether scaling up from R&D, navigating clinical trials or optimizing cryopreservation protocols for commercial production, we provide the tools and experience to streamline your workflow and safeguard your therapies.

Work with experts who understand your biopreservation challenges

Notch-Right-25px
Notch-Bottom-25px

Collaborative and comprehensive CDMO support

At BioLife Solutions, we partner with leading contract development and manufacturing organizations (CDMOs) to enhance their biopreservation and cell processing capabilities. By providing advanced tools, regulatory support, and process optimization strategies, we empower CDMOs to better serve therapy developers, ensuring quality, consistency, and scalability in cell therapy manufacturing.

Regulatory
readiness

Navigating the complex regulatory landscape of cell and gene therapy requires a proactive approach. BioLife Solutions offers experienced regulatory support to help prepare your biopreservation and cell processing methods to meet global standards. From IND and BLA submissions to compliance with GMP, FDA, and EMA guidelines, our solutions help streamline approval pathways.

Notch-Left-25px
Notch-Bottom-25px

STORE

CellSeal®
CryoCase

Alleviate CGT container challenges like fracture risk, bag burping or high rates of particulates

Notch-Right-25px
Notch-Bottom-25px

Data-driven
decision making

Stay ahead with our comprehensive Evidence Library, a curated collection of scientific publications, white papers, and case studies demonstrating the efficacy of BioLife Solutions’ technologies. Access peer-reviewed research, real-world application data, and expert insights to support your bioprocessing and regulatory strategies.

Insights

May 21, 2025

Designing the Ideal Cryostorage Container for CGT

April 18, 2025

The Cell Summit ’25: A Must-Attend Event for Innovators in Cell & Gene Therapy

March 27, 2025

Optimizing Biopreservation Strategies for Apheresis-Derived Cells in Immunotherapeutic Applications

February 19, 2025

How to prepare early for regulatory submissions from IND to BLA

Preserve, protect and expand cell performance

Mastering
Biopreservation

Ensure Regulatory Submission Readiness

Automate & Close
CGT Processes

Protect & Expand
Cell Performance